Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eflornithine + Nifurtimox for Late-Stage Human African Trypanosomiasis
NCT00489658Phase 3Terminated
- Sponsor
- Illumina
- Start
- Oct 2002
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of eflornithine, nifurtimox in human African trypanosomiasis (HAT), sponsored by Illumina. Started Oct 2002; status: terminated.
02
Drugs
eflornithinenifurtimox
03
Conditions
human African trypanosomiasis (HAT)
Beyond the preview
Go deeper on NCT00489658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00489658.